Key Investigators

Principal Investigator

ProviderTuya Pal, MD, FACMG 
Dr. Tuya Pal is a board-certified clinical geneticist based at the Vanderbilt-Ingram Cancer Center, an NCI-designated Comprehensive Cancer Center in Nashville, Tennessee. Dr. Pal is also the Associate Director of Cancer Health Disparities.






Georgia L. Wiesner, MD, MS
Dr. Georgia L. Wiesner is an Ingram Professor of Cancer Research, Professor of Medicine in the Division of Genetic Medicine and the Director of the new Clinical and Translational Hereditary Cancer Program for the Vanderbilt-Ingram Cancer Center. For further information on Dr. Wiesner, click here.


VadaparampilSusan_2926Susan Vadaparampil, PhD, MPH
Dr. Susan Vadaparampil is a behavioral scientist with an interest in uptake and outcomes related to genetic counseling and testing for hereditary breast cancer. Her research program focuses on increasing awareness, knowledge, and risk appropriate utilization of genetics services among patients and health care providers. For further information on Dr. Vadaparampil, click here.





Deborah Cragun, PhD, CGC 
Dr. Deborah Cragun earned a doctoral degree in the Department of Community and Family Health at the University of South Florida’s College of Public Health. She received her master of science degree from the University of Cincinnati’s genetic counseling program and was certified by the American Board of Genetic Counseling in 2005. She has worked as a clinical genetic counselor at Cincinnati Children’s Hospital for four years and at Moffitt Cancer Center since 2011. She completed her postdoctoral research fellowship in molecular and genetic epidemiology within the division of Population Sciences at Moffitt Cancer Center. She is currently an assistant professor at the University of South Florida in the College of Public Health where she is the program director for the newly approved and sole genetic counseling training program within the state of Florida. For further information on Dr. Cragun, click here.


Alvaro Monteiro
Alvaro NA Monteiro, PhD
Dr. Alvaro Monteiro is an experienced molecular geneticist who pioneered the field of BRCA1 functional analysis in 1996 with his studies on the role of BRCA1 in transcriptional regulation and its interactions with p53. He is an internationally recognized expert in the field of VUS related to the BRCA genes. For further information on Dr. Monteiro, click here.



ResearcherCatherine M. Phelan, PhD, MD, MMS
Dr. Catherine Phelan is a molecular geneticist. Her research program focuses on investigating genetic susceptibility to ovarian cancer. Additionally, Dr. Phelan has research interests in high-risk breast and ovarian cancer genes and cancer health disparities. For further information on Dr. Phelan, click here.